CD274 and neoplasm: PD-L1 expression, one of the most commonly chosen predictive markers, has been proven to be imperfect, because of the heterogeneity within the tumoral tissue, the possible variations as time progresses and the tumor is exposed to different therapies, and the variety of techniques used to assess it.